뉴로크린 바이오사이언시스
NBIX · 최근 20건
0
매수
20
매도
−$11.8M
순매수
거래 내역
Onyia Jude
Chief Scientific Officer · 2026. 8. 4.
−
매도
Norwalk Leslie V
Director · 2026. 7. 29.
−$117K
매도
Norwalk Leslie V
Director · 2026. 7. 28.
−$228K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 10.
−$791K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 10.
−$463K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 9.
−$1.5M
매도
Lippoldt Darin
Chief Legal Officer · 2026. 7. 9.
−$815K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 7. 9.
−$1.8M
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 9.
−$873K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 8.
−$283K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 8.
−$489K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 7.
−$607K
매도
Delaet Ingrid
Chief Regulatory Officer · 2026. 7. 7.
−$352K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 29.
−$661K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 29.
−$1.4M
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 29.
−$138K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 29.
−$289K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 26.
−$34K
매도
Lippoldt Darin
Chief Legal Officer · 2026. 6. 26.
−$16K
매도
Onyia Jude
Chief Scientific Officer · 2026. 5. 27.
−$932K
매도